中财网 中财网股票行情
川宁生物(301301)财务分析指标    年份：
截止日期2025-06-302025-03-312024-12-312024-09-302024-06-30
营业总收入(万元)234858.40129694.96575830.77445626.56319542.67
营业收入(万元)234858.40129694.96575830.77445626.56319542.67
营业总成本(万元)178226.3094949.47407014.38316061.82226406.29
营业成本(万元)150626.4181275.61366309.21285999.02206705.32
净利润(万元)45485.8328821.85140022.48107591.8576630.41
归属于母公司的净利润(万元)45485.8328821.85140032.41107591.8576630.41
营业利润(万元)57543.1235333.18168776.29129471.5591968.05
利润总额(万元)55950.3235000.27167509.18127792.2190915.71
少数股东损益(万元)-28.26-1.192.613.852.35
基本每股收益(元)0.20(元)0.13(元)0.63(元)0.48(元)0.34(元)
稀释每股收益(元)0.20(元)0.13(元)0.63(元)0.48(元)0.34(元)
非经常性损益(万元)-158.35517.97190.52101.31--
扣除非经常性损益后净利润(万元)45644.1828303.89139841.90107490.5476557.60
总资产(万元)1015930.431073254.331055358.001055137.651059916.51
总负债(万元)237232.34252534.62263716.41296216.53332842.52
归属于母公司股东权益合计(万元)776843.47818838.02789758.70757036.99725784.47
股东权益合计(万元)778698.09820719.71791641.58758921.12727073.99
实收资本(股本)(万元)223008.50222716.00222716.00222716.00222716.00
资本公积(万元)329867.17328684.92328427.46328136.38327845.29
未分配利润(万元)191445.82234915.12206093.27188952.49157991.05
经营活动产生的现金流量净额(万元)39148.3811658.45179106.7387525.9777242.65
经营活动现金流入小计(万元)165289.4464816.35478311.20316566.07221156.13
经营活动现金流出小计(万元)126141.0653157.89299204.47229040.10143913.48
投资活动产生的现金流量净额(万元)-4499.95-22250.15-10621.72-11148.26-7016.54
投资活动现金流入小计(万元)96156.4620046.4420618.4120114.5424.62
投资活动现金流出小计(万元)100656.4142296.5931240.1431262.817041.16
筹资活动产生的现金流量净额(万元)-62675.74-2875.14-136106.92-90413.04-54651.11
筹资活动现金流入小计(万元)1293.550.0080619.1971619.1934026.09
筹资活动现金流出小计(万元)63969.292875.14216726.11162032.2388677.20
期末现金及现金等价物余额(万元)80833.4895264.14108833.1761891.5391675.95
最后修改日期2025-08-262025-04-292025-04-222024-10-222024-08-26
↑返回页顶↑

转至川宁生物（301301）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。